American Academy of Neurology Issues Evidence-in-Focus Article on Aducanumab
February 24, 2022
February 24, 2022
MINNEAPOLIS, Minnesota, Feb. 24 (TNSJou) -- The American Academy of Neurology issued the following news release:
To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's disease, the American Academy of Neurology (AAN) has issued an evidence-in-focus article, published in the February 23, 2022, online issue of Neurology(R), the medical journal of the AAN. The article also includes a discussion of the safety, . . .
To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's disease, the American Academy of Neurology (AAN) has issued an evidence-in-focus article, published in the February 23, 2022, online issue of Neurology(R), the medical journal of the AAN. The article also includes a discussion of the safety, . . .